Clinical Trials

Solid Tumor

NCT05982522 2026-03-27

IN10018 Combination Therapy in Previously-treated Solid Tumors

Solid Tumor

NCT06654050 2026-03-17

Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma

Mesothelioma, Malignant, Mesothelioma

NCT04344652 2025-09-26

Photoscreening for Retinoblastoma

Retinoblastoma

NCT06235541 2025-07-17

A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

NCT06719973 2025-06-17

Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)

Advanced Solid Tumors

NCT06597786 2025-03-17

A Study of Exercise Therapy in People With Solid Tumor Cancer

Solid Tumor Cancer

NCT06365970 2025-02-03

Niraparib and Dostarlimab for Patients With MMR-D/MSI-H Colorectal Cancers

GastrointestinalOther solid neoplasm

MMR-D/MSI-H Colorectal Cancers

NCT06560138 2025-01-07

A Trial of SHR-4602 Infusion in Patients With SHR-4602 in Subjects With HER2-expressing or HER2-mutated Locally Advanced or Metastatic Solid Tumors

HER2-expressing or HER2-mutated Locally or Metastatic Solid Tumors

NCT06331598 2024-12-24

IMperator

Solid Tumors

NCT05231733 2024-10-31

Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors

Solid Tumors

NCT03973333 2024-10-18

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

Phase EARLY_PHASE1 Withdrawn

Select Advanced Solid Tumors

NCT05515692 2024-07-23

Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host Disease

OtherOther solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT06219499 2024-04-03

Safety, Tolerability, Immunogenicity and Pharmacokinetics of ONC-841

Phase EARLY_PHASE1 Withdrawn

Advanced Solid Tumor

NCT03905538 2024-03-01

Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid Tumors

Solid Tumor

NCT05375825 2024-02-02

Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

MyeloidOther solid neoplasmThoracic

Myeloproliferative Disorder, Chronic, with Eosinophilia, Mesothelioma, Malignant, Carcinoma, Pleural Effusion, Malignant

NCT05099536 2024-01-31

3D011-08 Monotherapy in Subjects With Advanced Solid Tumors

Solid Tumor, Adult

NCT05644626 2023-11-29

Safety, Pharmacokinetics and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab in Participants With Solid Tumors in Chinese Participants

Solid Tumors

NCT05791474 2023-11-29

ATI-2231 in Advanced Solid Tumor Malignancies

Advanced Solid Tumor

NCT06090318 2023-10-19

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

DermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Renal Cell, Melanoma, Mesothelioma, Stomach Neoplasms

NCT05284214 2023-09-15

SALIENT

Solid Tumor

NCT05582031 2023-06-07

REFIT-MSS

GastrointestinalOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Anus Neoplasms, Sarcoma, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT05531708 2023-03-01

Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid Tumors

Mesothelin-positive Advanced Refractory Solid Tumors

NCT03789773 2023-02-01

Holographic Mm-Wave Imaging in Patients Undergoing Radiation Therapy

Unspecified Adult Solid Tumor

NCT05381935 2023-01-31

A Study of ES014 (Anti-CD39/TGF-β Bispecific Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors

Advanced Solid Tumor

NCT04797468 2023-01-17

A Phase 1 Study of the CD73 Inhibitor(HLX23) Alone in Participants With Solid Tumor

Advanced Solid Tumor

NCT04316169 2022-12-23

Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

BreastOther solid neoplasm

Solid Tumor

NCT05469490 2022-09-30

Safety of Navoximod and NLG802 With Stereotactic Body Radiotherapy (SBRT) Treatment of Advanced Solid Tumors

Advanced Solid Tumors

NCT04878484 2022-09-02

Evaluate TCRT-ESO-A2 Autologous T Cells Expressing TCR Specific for NY-ESO-1 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

NCT03427320 2022-07-11

Imaging of Advanced Tumours Using [131]I-IAZA

Locally Advanced Solid Tumors

NCT05165849 2022-05-20

A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors

Solid Tumor

NCT05242926 2022-02-16

Absorption and Excretion of Oral Docetaxel

Solid Tumor, Adult

NCT05177276 2022-01-04

Selinexor Combination Ph 1 Study

Solid Tumor Malignancy

NCT04757090 2021-12-23

89Zr-Trastuzumab PET/CT in Subjects With Previously Treated HER2-Positive Solid Tumors Scheduled to Receive Treatment With MT-5111

HER2-positive Solid Tumor

NCT04429204 2021-06-14

Cryoablation for the Promotion of Local Tumor Infiltration in Patients With Mesothelioma

Mesothelioma

NCT03786419 2021-05-13

A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma

Mesothelioma, Malignant, Thoracic Neoplasms

NCT03706274 2021-05-05

PROCLAIM-CX-188: A Trial to Find Safe and Active Doses of an Investigational Drug CX-188 for Patients With Solid Tumors

Solid Tumor, Adult

NCT03728205 2021-04-27

Yoga for Solid Tumor

Solid Tumor, Adult

NCT04201145 2020-11-17

Pembrolizumab + Defactinib In Pleural Mesothelioma

Mesothelioma, Malignant

NCT03443622 2020-10-22

Phase I Study of SC-43 Oral Solution in Subjects With Refractory Solid Tumors

Refractory Solid Tumor

NCT03920839 2020-04-24

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

Parkinson Disease 4, Autosomal Dominant Lewy Body, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

NCT02691780 2019-12-30

Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid Tumors

Refractory Solid Tumors

NCT02747537 2019-09-09

Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan

Pediatric Solid Tumors

NCT03147976 2019-08-28

QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors

Solid Tumor

NCT03166176 2019-05-20

TSC1/2_SC

Solid Tumor

NCT03166904 2019-05-20

RICTOR_SC

Solid Tumor

NCT02106559 2019-03-21

Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

NCT02845414 2018-10-03

Study of CD133KDEL Toxin in the Treatment for Solid Tumors

Solid Tumors

NCT00997360 2018-09-27

Study of PKI-179 Administered Orally to Subjects With Solid Tumors

Advanced Malignant Solid Tumors

NCT01325753 2018-07-03

Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body